Valacyclovir hydrochloride fed study
Showing 1 - 25 of 3,350
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
Herpes Simplex, HIV, Chickenpox Trial (Valacyclovir HCl)
Withdrawn
- Herpes Simplex
- +2 more
- Valacyclovir hydrochloride
- (no location specified)
Oct 28, 2021
Mild Cognitive Impairment, Herpes Simplex 1, Herpes Simplex 2 Trial in New York (Valacyclovir HCl 500mg caplet, Placebo sugar
Recruiting
- Mild Cognitive Impairment
- +2 more
- Valacyclovir hydrochloride 500g caplet
- Placebo sugar pill caplet
-
New York, New YorkNew York State Psychiatric Institute
Dec 9, 2021
Healthy Volunteers Trial in Seoul (GC2129A(Period 1), Linaglptin 5mg and Metformin Hydrocholoride 1000mg(Period 1),
Recruiting
- Healthy Volunteers
- GC2129A(Period 1)
- +3 more
-
Seoul, Korea, Republic ofH Plus YangJi Hospital
Feb 6, 2023
Pharmacokinetics Trial in Québec (DFD-29 (Minocycline) Fasting, DFD-29 (Minocycline) Fed, Solodyn (Minocycline) Fasting)
Active, not recruiting
- Pharmacokinetics
- DFD-29 (Minocycline) Fasting
- +2 more
-
Québec, CanadaCRO
Jul 7, 2022
Healthy Trial in Christchurch (SP-104, Naltrexone Hydrochloride 50Mg Oral Tablet)
Completed
- Healthy
- SP-104
- Naltrexone Hydrochloride 50Mg Oral Tablet
-
Christchurch, New ZealandChristchurch Clinical Studies Trust (NZCR)
Apr 29, 2022
Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)
Completed
- Healthy
- Glucophage® XR Test
- Glucophage® XR Reference
-
Daejeon, Korea, Republic ofClinical Trials Center, Chungnam National University Hospital
Mar 30, 2022
Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)
Recruiting
- Healthy
- Test Glucophage® XR
- Reference Glucophage® XR
-
Darmstadt, GermanyResearch Site
Aug 10, 2022
Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)
Completed
- Bioequivalence
- Type 2 Diabetes
- Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Sep 20, 2022
Attention-Deficit/Hyperactivity Disorder Trial in South Miami, Durham (Methylphenidate HCl ER Capsules, 10 mg, Methylphenidate
Completed
- Attention-Deficit/Hyperactivity Disorder
- Methylphenidate HCl ER Capsules, 10 mg
- +2 more
-
South Miami, Florida
- +1 more
Oct 27, 2021
Breast Cancer and Ovarian Cancer Trial (SPARC-08-038, Ref-08-038)
Completed
- Breast Cancer and Ovarian Cancer
- (no location specified)
Jul 22, 2021
Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Tumor of Lung, Metastatic Uveal Melanoma Trial in Houston
Terminated
- Lung Squamous Cell Carcinoma Stage IV
- +2 more
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Hospital
Nov 17, 2020
Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
- Galvumet® Film Coated Tablets (850 mg / 50 mg)
-
Bab Souika, Tunise, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023
Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /
Completed
- Fed Conditions
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
- Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
-
Tunis, TunisiaCentre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023
Healthy Trial in Amman (: Amaryl® M IR 2/1000)
Withdrawn
- Healthy
- : Amaryl® M IR 2/1000
-
Amman, JordanArab Pharmaceutical industry Consulting/ Pharmaceutical Research
Sep 16, 2020
Alzheimer, Herpes Simplex 1, Herpes Simplex 2 Trial in Phoenix, New York (Valacyclovir, Placebo)
Active, not recruiting
- Alzheimer Disease
- +2 more
- Valacyclovir
- Placebo
-
Phoenix, Arizona
- +2 more
Apr 21, 2022
DW6014 Trial in Cheongju-si (DW6014)
Not yet recruiting
- DW6014
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
Fuchs' Endothelial Dystrophy, Cataract Trial in Singapore (Ripasudil, Placebo)
Recruiting
- Fuchs' Endothelial Dystrophy
- Cataract
- Ripasudil
- Placebo
-
Singapore, SingaporeSingapore National Eye Centre
Sep 15, 2023
Duchenne Muscular Dystrophy Trial (Givinostat, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- Givinostat
- Placebo
- (no location specified)
Jun 27, 2023
Healthy Trial in Fargo (Benazepril HCl 40 mg Tablets, Lotensin® 40 mg Tablets)
Completed
- Healthy
- Benazepril HCl 40 mg Tablets
- Lotensin® 40 mg Tablets
-
Fargo, North DakotaPRACS Institute, Ltd.
Jan 6, 2020
Healthy Subjects Trial in Qingdao (Sitagliptin Phosphate/metformin Hydrochloride Tablets(JANUMET®,50mg/850mg), Sitagliptin
Completed
- Healthy Subjects
- Sitagliptin Phosphate/metformin Hydrochloride Tablets(JANUMET®,50mg/850mg)
- Sitagliptin Phosphate/metformin Hydrochloride Tablets (50mg/850mg)
-
Qingdao, Shanndong, ChinaPhase I Clinical Research Center
May 5, 2021
Bioequivalence Study Trial in Beijing (Venlafaxine Hydrochloride Sustained-Release Capsules 75 mg, EFEXOR® XR)
Unknown status
- Bioequivalence Study
- Venlafaxine Hydrochloride Sustained-Release Capsules 75 mg
- EFEXOR® XR
-
Beijing, Beijing, ChinaInstitution of Drug Clinical Trials
Jan 14, 2020
Neonatal Herpes Simplex Infection Trial in Birmingham (Valacyclovir)
Recruiting
- Neonatal Herpes Simplex Infection
-
Birmingham, AlabamaUniversity of Alabama - Children's of Alabama
Sep 12, 2022